Compounds of formula [I]
1
in which:
W may represent a —(CH
2
)
2
—, —(CH
2
)
3
—, —CH
2
—C≡C— or —CH
2
—CH═CH— group,
R
2
may in particular represent a piperidyl group, an optionally substituted 1,2,3,6-tetrahydropyridyl group, a hexahydro-1H-azepinyl group, an optionally substituted piperazinyl group or a morpholinyl group,
R
3
may in particular represent a group —COR
1
,
A may in particular represent an optionally substituted phenyl group, a heterocycle or a cyclopentyl group, and
B may in particular represent a pyridyl group, an aminopyrazinyl group, an aminopyridazinyl group, a pyrimidinyl group optionally substituted with an amino group, piperidyl group or an aminopyridyl group optionally substituted on the pyridine with a (C
1
-C
4
)alkyl or (C
1
-C
4
)alkoxy group, the amino group possibly also being substituted with a (C
1
-C
4
)alkyl group,
their preparation and their therapeutic application.
式为[I]1的化合物中:W可以代表一个—(
CH2)2—、—( )3—、— —C≡C—或— —CH═CH—基团,R2特别可以代表
哌啶基团、一个可选择地取代的
1,2,3,6-四氢吡啶基团、一个六氢-1H-氮杂环庚基团、一个可选择地取代的
哌嗪基团或吗啉基团,R3特别可以代表一个—COR1基团,A特别可以代表一个可选择地取代的苯基团、一个杂环或一个环戊基团,B特别可以代表一个
吡啶基团、一个
氨基吡嗪基团、一个
氨基吡啶基团,一个可选择地取代的
嘧啶基团,该
嘧啶基团上可选择地取代有
氨基、
哌啶基团或可选择地取代的苯基团,该
氨基团还可能被(C1-C4)烷基或(C1-C4)烷氧基取代,它们的制备及其治疗应用。